TALL-1 receptor molecules and uses thereof
US7256015B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Sep 20, 2002 |
| Grant date | Aug 14, 2007 |
| Priority date | — |
| Expiry date | Jan 13, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides tumor necrosis factor and apoptosis ligand-related leukocyte-expressed ligand 1 receptor (TALL-1R) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing TALL-1R polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with TALL-1R polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.